CRISPR/Cas9屏幕用于癌细胞中必不可少的MYC结合的E盒的全基因组查询
Marta Kazimierska1,2, Marta Podralska1, Magdalena Żurawek1
1Institute of Human Genetics, Polish Academy of Sciences, Poznań, Poland.
Molecular oncology
|July 31, 2023
概括
研究人员确定了对MYC驱动的癌症生长至关重要的基本E盒和基因. 破坏这些E盒影响MYC结合,基因表达和癌细胞增殖,提供新的治疗点.
科学领域:
- 在瘤学瘤学.
- 分子生物学分子生物学
- 遗传学 遗传学 是一个
背景情况:
- 在癌症的发展和维持中,MYC原瘤基因至关重要.
- MYC通过结合特定的E盒DNA序列来调节基因表达.
- 缺乏一个全面的分析,将MYC结合的E-box与它们的癌症相关的目标基因联系起来.
研究的目的:
- 系统地识别癌症中MYC调节的基本E盒和下游基因.
- 开发和验证一种基于CRISPR/Cas9的查方法,用于MYC依赖的癌症脆弱性.
主要方法:
- 全基因组的CRISPR/Cas9图书馆屏幕针对电子盒和蛋白质编码基因.
- 在四个依赖MYC的癌细胞系 (K562,ST486,HepG2,MCF7) 中进行高通量查.
- 验证E-box破坏对MYC结合,基因表达,增殖和瘤生长的影响.
主要成果:
- 确定了几个重要的E盒和基因,这些基因对MYC驱动的癌细胞生长至关重要.
- 发现了常见的和特定于细胞类型的MYC调节基因,这些基因参与了癌症途径.
- 证实E-box的干扰会损害MYC结合,改变向基因表达,并在体内减少癌细胞增殖和瘤生长.
结论:
- 这项研究为剖析癌症中MYC依赖基因调节提供了经过验证的工具.
- 这些发现突出了MYC调节的关键基因和E-box作为潜在的治疗点.
- 这种方法为了解和利用MYC驱动的癌症漏洞提供了新的途径.
相关概念视频
01:28CRISPR/Cas9 Genome Editing
61
The CRISPR-Cas system serves as a bacterial defense mechanism against invading genetic elements such as viruses and plasmids, forming the foundation for its adaptation as a powerful genome-editing tool. Originally discovered in prokaryotes, this system has been repurposed to revolutionize genetic engineering across a wide range of organisms, including plants, animals, and humans. The core component, Cas9, is an endonuclease derived from Streptococcus pyogenes, capable of introducing...
61
01:59CRISPR
52.4K
Genome editing technologies allow scientists to modify an organism’s DNA via the addition, removal, or rearrangement of genetic material at specific genomic locations. These types of techniques could potentially be used to cure genetic disorders such as hemophilia and sickle cell anemia. One popular and widely used DNA-editing research tool that could lead to safe and effective cures for genetic disorders is the CRISPR-Cas9 system. CRISPR-Cas9 stands for Clustered Regularly Interspaced...
52.4K
01:06Induced Pluripotent Stem Cells
4.2K
Stem cells are undifferentiated cells that divide and produce different cell types. Ordinarily, cells that have differentiated into a specific cell type are terminally differentiated; however, scientists have found a way to reprogram these mature cells so that they dedifferentiate and return to an unspecialized, proliferative state. These cells are pluripotent like embryonic stem cells—able to produce all cell types—and are called induced pluripotent stem cells (iPSCs).
Somatic...
Somatic...
4.2K